Risk factors of fracture following curettage for bone giant cell tumors of the extremities

Abstract Background Following curettage of giant cell tumor of bone (GCTB), it is common to fill the cavity with polymethylmethacrylate (PMMA) bone cement, bone allograft, or artificial bone to maintain bone strength; however, there is a 2–14% risk of postoperative fractures. We conducted this retro...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shinji Tsukamoto, Andreas F. Mavrogenis, Manabu Akahane, Kanya Honoki, Akira Kido, Yasuhito Tanaka, Davide Maria Donati, Costantino Errani
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2022-05-01
Edice:	BMC Musculoskeletal Disorders
Témata:	Giant cell tumor of bone Curettage Fracture Denosumab Cement Bone grafting
On-line přístup:	https://doi.org/10.1186/s12891-022-05447-x
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!